HBOT Conversations:
Elena Schertz & Extivita RTP
Elena Schertz, NP of Extivita-RTP in North Carolina, discusses how her clinic is actively healing the injured and sick with hyperbaric oxygen therapy (HBOT), including veterans, sports athletes and COVID long-haulers. She explains the proven benefits of HBOT – what it is, who are candidates for the therapy, and how each session saturates a patient’s blood plasma with oxygen for ultimate healing powers.
Extivita-RTP offers a positive environment for healing, and she encourages anyone seeking a better quality of life to come visit them and experience the wonder of hyperbaric oxygen therapy.
Watch the Podcast
HBOT News podcast host, Edward diGirolamo, talks with guest, Elena Schertz, NP of Extivita-RTP, about how her clinic is actively healing the injured and sick with hyperbaric oxygen therapy (HBOT), including veterans, sports athletes and COVID long-haulers. She explains the proven benefits of HBOT – what it is, who are candidates for the therapy, and how each session saturates a patient’s blood plasma with oxygen for ultimate healing powers.
Elena reveals their successes treating TBI and PTSD, and why the therapies at Extivita are even leading to the patient’s elimination of suicidal thoughts. Since veterans are at high risk of suicide due to the grave nature of combat, priority is being taken to treat these American heroes with HBOT at low or no cost. North Carolina’s veteran funding is discussed, while Elena expresses her hope that the state will eventually expand funding to include other beneficial therapies.
The topic of treating COVID long-haulers arise, and Elena makes a claim with absolute certainty that 99% of the COVID long-haulers who come through their doors are significantly better after going through HBOT sessions and nutritional IV regiments, with 95% of them eventually returning to their baseline.
Elena ends the podcast interview raving about her experienced clinical staff, explaining how they celebrate every milestone with their patients relishing in the rewards of making a difference and saving lives. They offer a positive environment for healing, and she encourages anyone seeking a better quality of life to come experience Extivita-RTP and the wonder of hyperbaric oxygen therapy.
Guest
Elena Schertz, NP - Clinic Manager at Extivita RTP
Elena attained her Bachelors of Science in Nursing from Michigan State University and received her Masters of Science in Nursing from Simmons University in Boston, MA. She has been practicing integrative medicine since 2010 and is currently working on her certification in functional medicine from the Institute of Functional Medicine.
Elena worked as a nurse in the pediatric oncology, cardiac, and surgical units at UNC hospitals for 15 years before deciding to work in integrative medicine. After years of working as a nurse, she decided to pursue her graduate degree, completing her masters with honors. She is board certified as a Family Nurse Practitioner (FNP) through the American Nurses Credentialing Center.
Elena’s passion for integrative medicine comes from her knowledge that the mind, body and psych/social/spiritual systems are not separate. The focus of Elena’s practice is to approach each of her patient’s healing process from the perspective of the whole, supported and grounded in safety and evidence-based medicine. She also maintains close consultative relationships with experts in the field to promote and enhance wellness for her patients. Elena joined the wonderful Extivita team in March 2019 and is thrilled to be a part of advancing health and wellness through hyperbaric medicine.
Extivita-RTP – Hyperbaric Oxygen Therapy Clinic
2012-D TW Alexander Drive
Durham, NC 27709
919-354-3775
919-354-3776
contact@extivita.org
https://www.extivita.org/
Subscribe Now, It’s Free !
Recent HBOT News
Clinical Trial – ED50 and ED95 of Isobaric Bupivacaine for Post-Partum Bilateral Tubal Ligation
Spinal anesthesia is one of the preferred anesthetic techniques for post-partum bilateral
tubal ligation (PBTL). Bupivacaine is the most commonly used local anesthetic for neuraxial
anesthesia for post-partum tubal ligation. Typically, hyperbaric bupivacaine would be
injected into the spinal (intrathecal) space via a spinal needle; however, ongoing medication
shortages have resulted in limited availability on a local and national level. One proposed
alternative is isobaric bupivacaine; however, studies investigating its use for post-partum
bilateral tubal ligation are limited.
The purpose of this prospective study is to determine the minimal effective dose (ED50 and
ED95) of isobaric bupivacaine for adequate anesthesia during post-partum tubal ligation after
vaginal delivery.
A Case of Refractory Hemorrhagic Cystitis in which Bleeding Control was Finally Achieved by Cystectomy.
A 60-year-old man presented at our hospital with gross hematuria. He had been treated for nephrotic syndrome with cyclophosphamide and steroids since he was in his 20s. We detected diffuse hemorrhagic cystitis on cystoscopy and diagnosed him with cyclophosphamide-induced hemorrhagic cystitis. He was hospitalized due to clot retention. We treated him with blood transfusion for severe anemia and conducted continuous bladder irrigation. We performed hyperbaric oxygen therapy and transurethral electric coagulation, and increased the steroid dose. However, we could not control the hematuria. Finally, we performed cystectomy, and he is now well without hematuria. Although cystectomy is the final option, it is important to decide it in a timely manner because a delay decreases the quality of life.
Erratum: Effect of hyperbaric oxygenation therapy on post-concussion syndrome.
The present review evaluated the effect of hyperbaric oxygenation (HBO) therapy on post-concussion syndrome (PCS). Searches for publications from the earliest date possible up until the first week of 2016 were conducted using the electronic databases Cochrane, EBSCOhost, Embase, Ovid MEDLINE, PubMed and Web of Science. Additional trials were identified through reference list scanning. Randomized controlled trials assessing the effectiveness of HBO therapy in PCS were selected and tested for eligibility for inclusion in the present review.